NCT02499003 2022-03-31GOAL: GA101 Plus Pixantrone for Relapsed Aggressive LymphomaJohannes Gutenberg University MainzPhase 2 Completed70 enrolled
NCT00060671 2015-01-19Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's LymphomaCTI BioPharmaPhase 3 Terminated800 enrolled
NCT00060684 2015-01-19Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's LymphomaCTI BioPharmaPhase 1 Completed30 enrolled